Next 10 |
home / stock / bax / bax articles
Monday, the FDA granted 510(k) clearance to Baxter International Inc’s (NYSE:BAX) Novum IQ large volume infusion pump (LV...
Tuesday, Novo Nordisk A/S (NYSE:NVO) released the headline results from the kidney outcomes trial, FLOW. The trial achieved its primary e...
Thursday, Baxter International Inc (NYSE: BAX) posted a fourth-quarter 2023 revenue of $3.89 billion, which beat the consensus of $3...
Baxter International Inc (NYSE: BAX) posted Q3 revenue of $3.71 billion, which beat the consensus of $3.69 billion, up 3% Y/Y on a report...
Gainers Tempest Therapeutics, Inc. (NASDAQ: TPST) shares jumped 1067% to $2.80 after the company released new data demonstrating superiority of TP...
DaVita Inc (NYSE: DVA), Fresenius Medical Care AG (NYSE: FMS), and Baxter International Inc (NYSE: BAX) shares fell sharpl...
U.S. stock futures traded higher this morning on Wednesday. Here are some big stocks recording losses in today’s pre-market trading session. ...
NEW YORK, Sept. 30, 2023 (GLOBE NEWSWIRE) -- ImmunityBio, Inc. (NASDAQ:IBRX) Lifshitz Law PLLC announces investigation into possible securities...
SAN DIEGO, Sept. 26, 2023 (GLOBE NEWSWIRE) -- Baxter International, Inc. (NYSE:BAX) Johnson Fistel, LLP is investigating potential claims on be...
News, Short Squeeze, Breakout and More Instantly...
Baxter International Inc. Company Name:
BAX Stock Symbol:
NYSE Market:
Baxter International Inc. Website:
Five new launches reinforce Baxter’s focus on differentiated products and enhance the company’s Pharmaceuticals portfolio in critical therapeutic areas Products feature ready-to-use formulations to help support patient safety and offer added convenience for healthcare profession...
Baxter International Inc. (NYSE:BAX), a global medtech leader, will host a conference call to discuss its first-quarter 2024 financial results on Thursday, May 2, 2024 at 7:30 a.m. Central Time. To participate in this conference call please follow this link https://registrations.events/direct/Q...